KOS PHARMACEUTICALS TO REPORT FOURTH QUARTER AND FULL YEAR RESULTS

Kos Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company, will announce results for the fourth quarter and full year ended December 31, 2005, before the market opens on Thursday, February 23, 2006. Following the release, Kos' senior management will host a conference call at 8:30 a.m. ET to discuss the Company's results.
Genetic Engineering News